Global Nucleic Acid Testing Market 2017-2021 - Country Forecasts and Supplier Shares - ResearchAndMarkets.com

DUBLIN--()--The "Global Nucleic Acid Testing/NAT Market Country Forecasts and Supplier Shares 2017-2021: Global Opportunities and Growth Strategies for Instrument and Reagent Suppliers" report has been added to ResearchAndMarkets.com's offering.

The NAT market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the NAT market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Report Highlights

  • Business and technological trends in seven major markets
  • Five-year test volume and sales forecasts
  • Market shares of leading competitors
  • Feature comparison of major analyzers
  • Profiles of market players and start-up firms developing innovative technologies and products
  • Specific product and business opportunities for instrument and consumable suppliers

Companies Mentioned

  • Abbott
  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Bio-Rad
  • Biokit
  • bioMerieux
  • Biotest
  • CellMark Forensics/LabCorpCepheid
  • Cepheid
  • Diadexus
  • Eiken
  • Elitech Group
  • Enzo
  • Exact Sciences
  • Fujirebio
  • Hologic/Gen-Probe
  • Illumina
  • Kreatech/Leica
  • Monogram Biosciences/LabCorp
  • Myriad Genetics
  • Ortho-Clinical Diagnostics
  • Perkin Elmer/Caliper
  • Proteome Sciences
  • Roche
  • Scienion
  • Sequenom
  • Shimadzu
  • Siemens
  • Takara Bio
  • Tecan Group
  • Thermo Fisher

Key Topics Covered:

I. Introduction

II. Major Product Development Opportunities

III. Design Criteria for Decentralized Testing Products

IV. Alternative Market Penetration Strategies

V. Potential Market Entry Barriers and Risks

VI. Worldwide Market and Technology Review

VII. Worldwide Market Overview

VIII. France Molecular Diagnostics Market

IX. Germany Molecular Diagnostics Market

X. Italy Molecular Diagnostics Market

XI. Japan Molecular Diagnostics Market

XII. Spain Molecular Diagnostics Market

XIII. U.K. Molecular Diagnostics Market

XIV. U.S.A. Molecular Diagnostics Market

XV. Competitive Assessments

XVI. Appendix: Major Universities and Research Centers

For more information about this report visit https://www.researchandmarkets.com/research/w9n3zj/global_nucleic?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: In Vitro Diagnostics, Molecular Diagnostics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: In Vitro Diagnostics, Molecular Diagnostics